Reasons for underuse of angiotensin-converting enzyme inhibitors in patients with heart failure and left ventricular dysfunction
Reasons for underuse of angiotensin-converting enzyme inhibitors in patients with heart failure and left ventricular dysfunction
复制标题
DOI：
10.1016/s0002-9149(97)00060-x
复制
发表时间：
1997-04-15
影响因子：
2.8
通讯作者：
OConnor, CM
中科院分区：
文献类型：
--
作者：
Bart, BA;Gattis, WA;OConnor, CM
我们回顾了242例因心力衰竭和射血分数小于或等于45%而住院超过1年的患者的记录，以评估血管紧张素转换酶抑制剂的使用。然而，一个重要的少数（8%）没有明显的原因，缺乏这种治疗，强调需要的战略，以增加使用这些有益的代理商。
We reviewed the records of 242 patients admitted over 1 year with heart failure and an ejection fraction less than or equal to 45% to assess the use of angiotensin-converting enzyme inhibitors, Most patients were treated with angiotensin-converting enzyme inhibitors. However, an important minority (8%) had no apparent reason for the lack of this treatment, highlighting the need for strategies to increase the use of these beneficial agents.